Empirical Use of Fluconazole in Critically Ill Patients: Good Study, but What Was the Hold-up?

  1. Samuel A. Shelburne, MD
  1. From the University of Texas MD Anderson Cancer Center, Houston, TX 77030.

    TO THE EDITOR:

    I would like to thank Schuster and colleagues (1) for the excellent article on the empirical use of fluconazole in critically ill patients at high risk for disseminated candidiasis. Their investigation provides valuable data to a broad array of clinicians and addresses an important but understudied area of biomedical research. However, I was troubled …

    Related Articles

    « Previous | Next Article »Table of Contents